Clinical Trial: Improving Compliance with Metformin


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Improving Compliance with Metformin

This study is currently recruiting patients.

Sponsored by:	Department of Veterans Affairs
Information provided by:	Department of Veterans Affairs

Purpose

This is a randomized controlled trial of adherence. The study involves monitoring and managing focused intervention in patients prescribed metformin.

Condition	Treatment or Intervention	Phase
Diabetes	Behavior: MEMS caps	Phase II

MedlinePlus related topics: Diabetes

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Further Study Details:

Study start: October 1999; Study completion: February 2002

The active intervention, MEMS Feedback, involves review of patients' medication-taking over the preceding weeks

Eligibility

Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both

Criteria

Metformin has been prescribed
Willing to use medication containers with MEMS caps
Capable of giving informed consent

Location and Contact Information

Connecticut
VA Connecticut Healthcare System, West Haven, Connecticut, 06516, United States; Recruiting

Marc I Rosen, MD 203-932-5711 Ext. 2112
Marc I. Rosen, Principal Investigator

Study chairs or principal investigators

Michael Rigsby, M.D.

More Information

Study ID Numbers: MHBS-047-98F
Record last reviewed: June 2001
Record first received: July 3, 2001
ClinicalTrials.gov Identifier: NCT00018616
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-10-27

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services